These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1486988)

  • 21. Quantitative method for determination of hemolytic activity of Clostridium septicum toxin.
    Takano S; Kondo H
    Jpn J Med Sci Biol; 1987 Apr; 40(2):47-59. PubMed ID: 3430819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Latent effects of haemolytic agents.
    Bergmann F; Kidron M
    J Gen Microbiol; 1966 Aug; 44(2):233-40. PubMed ID: 5969501
    [No Abstract]   [Full Text] [Related]  

  • 23. Advances in anticancer immunotoxin therapy.
    Alewine C; Hassan R; Pastan I
    Oncologist; 2015 Feb; 20(2):176-85. PubMed ID: 25561510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of an immunotoxin by linking a monoclonal antibody against the human epidermal growth factor receptor and a hemolytic toxin.
    Avila AD; Calderón CF; Pérez RM; Pons C; Pereda CM; Ortiz AR
    Biol Res; 2007; 40(2):173-83. PubMed ID: 18064354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-toxic perfringolysin O and α-toxin derivatives as potential vaccine candidates against bovine necrohaemorrhagic enteritis.
    Verherstraeten S; Goossens E; Valgaeren B; Pardon B; Timbermont L; Haesebrouck F; Ducatelle R; Deprez P; Van Immerseel F
    Vet J; 2016 Nov; 217():89-94. PubMed ID: 27810219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory Effect of Newly-Synthesized Chalcones on Hemolytic Activity of Methicillin-Resistant Staphylococcus aureus.
    Božić DD; Milenković MT; Ivković BM; Larsen AR; Cirković IB
    Pol J Microbiol; 2015; 64(4):379-82. PubMed ID: 26999958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Alpha and theta toxin Clostridium perfringens infection complicated by septic shock and hemolysis].
    Pastene B; Grégoire E; Blasco V; Albanèse J
    Ann Fr Anesth Reanim; 2014; 33(9-10):552-3. PubMed ID: 25154792
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification and assay of RTX family of cytolysins.
    Lobo AL; Welch RA
    Methods Enzymol; 1994; 235():667-78. PubMed ID: 8057935
    [No Abstract]   [Full Text] [Related]  

  • 29. Fast protein liquid chromatography for the isolation of Clostridium perfringens type A alpha-toxin.
    Eloy C; Fardel G; Flandrois JP
    J Chromatogr; 1985 Mar; 321(1):235-9. PubMed ID: 2859296
    [No Abstract]   [Full Text] [Related]  

  • 30. Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins.
    Griffin T; Raso V
    Cancer Res; 1991 Aug; 51(16):4316-22. PubMed ID: 1868454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serum inhibitors of Clostridium perfringens alpha toxin].
    Strnad V; Sobek V; Soucek A
    Cesk Epidemiol Mikrobiol Imunol; 1986 Apr; 35(2):102-7. PubMed ID: 2938745
    [No Abstract]   [Full Text] [Related]  

  • 32. Increase in membrane conductance and positive inotropic action of hemolysin produced by Vibrio parahaemolyticus on rabbit myocardium.
    Seyama L; Irisawa H; Honda T; Takeda T; Miwatani T
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 11():621-5. PubMed ID: 1031962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane disorganization induced by perfringolysin O (theta-toxin) of Clostridium perfringens--effect of toxin binding and self-assembly on liposomes.
    Iwamoto M; Nakamura M; Mitsui K; Ando S; Ohno-Iwashita Y
    Biochim Biophys Acta; 1993 Nov; 1153(1):89-96. PubMed ID: 8241254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer.
    Wawrzynczak EJ; Derbyshire EJ; Henry RV; Parnell GD; Smith A; Waibel R; Stahel RA
    Br J Cancer Suppl; 1991 Jun; 14():71-3. PubMed ID: 1645577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An immunotoxin cytotoxic for breast cancer cells in vitro.
    LeMaistre CF; Edwards DP; Krolick KA; McGuire WL
    Cancer Res; 1987 Feb; 47(3):730-4. PubMed ID: 3492266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotoxin treatment of cancer.
    Pastan I; Hassan R; FitzGerald DJ; Kreitman RJ
    Annu Rev Med; 2007; 58():221-37. PubMed ID: 17059365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro efficacy of anti-HIV immunotoxins targeted by various antibodies to the envelope protein.
    Pincus SH; Cole RL; Hersh EM; Lake D; Masuho Y; Durda PJ; McClure J
    J Immunol; 1991 Jun; 146(12):4315-24. PubMed ID: 1710247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxin-neutralizing antibodies protect against Clostridium perfringens-induced necrosis in an intestinal loop model for bovine necrohemorrhagic enteritis.
    Goossens E; Verherstraeten S; Valgaeren BR; Pardon B; Timbermont L; Schauvliege S; Rodrigo-Mocholí D; Haesebrouck F; Ducatelle R; Deprez PR; Van Immerseel F
    BMC Vet Res; 2016 Jun; 12(1):101. PubMed ID: 27297520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant antibody fragments and immunotoxin fusions for cancer therapy.
    Brinkmann U
    In Vivo; 2000; 14(1):21-7. PubMed ID: 10757057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A modified theta-toxin produced by limited proteolysis and methylation: a probe for the functional study of membrane cholesterol.
    Ohno-Iwashita Y; Iwamoto M; Ando S; Mitsui K; Iwashita S
    Biochim Biophys Acta; 1990 Apr; 1023(3):441-8. PubMed ID: 1692243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.